✦ LIBER ✦

In postmenopausal women with breast cancer, switching to exemestane increased disease-free survival compared to continuing tamoxifen

Book ID: 116416200
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 78 KB
Volume: 7
Category: Article
ISSN: 1361-259X
DOI: 10.1016/j.ebobgyn.2005.01.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness of switching to exeme

Cost-effectiveness of switching to exemestane versus continued tamoxifen as adjuvant therapy for postmenopausal women with primary breast cancer

✍ Nancy A. Risebrough; Shailendra Verma; Maureen Trudeau; Nicole Mittmann 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB 👁 1 views

## Abstract ## BACKGROUND. Sequential tamoxifen/exemestane therapy reportedly improves disease‐free survival in women with primary breast cancer compared with continued tamoxifen therapy. The objective of the current study was to assess the cost‐effectiveness of switching to exemestane after 2 to

Switching to exemestane after 2–3 years

Switching to exemestane after 2–3 years of adjuvant tamoxifen prolongs disease-free survival, but not overall survival, in postmenopausal women surviving primary breast cancer, compared with continuous tamoxifen: Abstracted from: Coombes RC, Hall E, Gibson LJ, et al. A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. N Engl J Med 2004;350:1081–92.

✍ Christina Davies 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 248 KB

Cost-Effectiveness of Switching to Exeme

Cost-Effectiveness of Switching to Exemestane after 2 to 3 Years of Therapy with Tamoxifen in Postmenopausal Women with Early-Stage Breast Cancer

✍ David Thompson; Douglas C. A. Taylor; Eduardo L. Montoya; Eric P. Winer; Stephen 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 171 KB

Changes in bone turnover and in bone mas

Changes in bone turnover and in bone mass in women with breast cancer switched from tamoxifen to exemestane

✍ S. Gonnelli; A. Cadirni; C. Caffarelli; R. Petrioli; A. Montagnani; M.B. Franci; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 289 KB

Compared to tamoxifen, letrozole increas

Compared to tamoxifen, letrozole increases tumor response in post-menopausal women with advanced breast cancer

✍ Visaharan Sivasubramaniam; Gary H. Lyman 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 98 KB

1–42 A Randomized Trial of Exemestane Af

1–42 A Randomized Trial of Exemestane After Two to Three Years of Tamoxifen Therapy in Postmenopausal Women With Primary Breast Cancer

✍ Buzdar, A.U. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 64 KB